HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

norlichexanthone

isolated from fungus P16; structure in first source

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - Xanthenes: 65
      - Xanthones: 211
        norlichexanthone: 3

Experts

1.	Chen, Haifeng: 1 article (02/2021)
2.	Chen, Junjie: 1 article (02/2021)
3.	Chen, Yongyan: 1 article (02/2021)
4.	Gao, Shuo: 1 article (02/2021)
5.	Ge, Mengmeng: 1 article (02/2021)
6.	Liao, Mingkai: 1 article (02/2021)
7.	Lin, Ting: 1 article (02/2021)
8.	Wang, Keqi: 1 article (02/2021)
9.	Wang, Maosi: 1 article (02/2021)
10.	Xu, Lin: 1 article (02/2021)

Related Diseases

1.	Atherosclerosis 07/01/2011 - "These findings suggest the possibility that norlichexanthone has the potential to treat and/or prevent lifestyle-related diseases, including metabolic syndrome, type 2 diabetes, atherosclerosis and cardiovascular diseases."
2.	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/01/2011 - "These findings suggest the possibility that norlichexanthone has the potential to treat and/or prevent lifestyle-related diseases, including metabolic syndrome, type 2 diabetes, atherosclerosis and cardiovascular diseases."
3.	Postmenopausal Osteoporosis 02/01/2021 - "Norlichexanthone purified from plant endophyte prevents postmenopausal osteoporosis by targeting ER α to inhibit RANKL signaling." 02/01/2021 - "Here, we defined that norlichexanthone (NOR), a natural product, is a ligand of estrogen receptor-alpha (ERα) and revealed its therapeutic potential for postmenopausal osteoporosis. "
4.	Parkinson Disease (Parkinson's Disease) 05/01/2019 - "As an outcome of this screening, 31 compounds out of 968 compounds from Afro Database (compounds from African medicinal plants) are predicted to be active as MAO-B inhibitor, Out of the 31 predicted active compounds, Norlichexanthone (ZINC05765089) is predicted to be most active against MAO-B with highest RF score 0.795181, along with the other top hits, could be the putative drug candidates for the prevention/ treatment of Parkinson's disease."
5.	Type 2 Diabetes Mellitus (MODY) 07/01/2011 - "These findings suggest the possibility that norlichexanthone has the potential to treat and/or prevent lifestyle-related diseases, including metabolic syndrome, type 2 diabetes, atherosclerosis and cardiovascular diseases."

Related Drugs and Biologics

1.	Estrogen Receptor alpha
2.	Monoamine Oxidase (MAO)
3.	Ligands